What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Gareth J. Morgan mostly deals with Multiple myeloma, Internal medicine, Surgery, Oncology and Bone marrow.
His study focuses on the intersection of Multiple myeloma and fields such as Cancer research with connections in the field of Natural killer cell.
The various areas that he examines in his Internal medicine study include Gastroenterology and Pathology.
In general Surgery study, his work on Autologous stem-cell transplantation, Melphalan, Zoledronic acid and Autologous transplantation often relates to the realm of Clodronic acid, thereby connecting several areas of interest.
The study incorporates disciplines such as Context, Survival rate, Cyclophosphamide, Retrospective cohort study and Hazard ratio in addition to Oncology.
His Bone marrow research is included under the broader classification of Immunology.
His most cited work include:
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. (2431 citations)
- International uniform response criteria for multiple myeloma (2049 citations)
- International staging system for multiple myeloma. (1912 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Multiple myeloma, Oncology, Immunology and Surgery are his primary areas of study.
His Internal medicine research includes themes of Gastroenterology and Cardiology.
His Multiple myeloma research is multidisciplinary, incorporating perspectives in Cancer research and Bone marrow, Pathology.
His studies in Oncology integrate themes in fields like Cancer, Clinical trial, Bioinformatics and Dexamethasone.
His Immunology research is mostly focused on the topic Antibody.
His Thalidomide research integrates issues from Regimen, Cyclophosphamide, Maintenance therapy and Melphalan.
He most often published in these fields:
- Internal medicine (47.86%)
- Multiple myeloma (45.69%)
- Oncology (23.62%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (47.86%)
- Multiple myeloma (45.69%)
- Oncology (23.62%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Multiple myeloma, Oncology, Cardiology and Cancer research.
His studies in Lenalidomide, Transplantation, Progression-free survival, Thalidomide and Cyclophosphamide are all subfields of Internal medicine research.
His Multiple myeloma research includes elements of Monoclonal gammopathy of undetermined significance, Computational biology, Bone marrow and Disease.
His Computational biology study combines topics from a wide range of disciplines, such as Gene and Whole genome sequencing.
Gareth J. Morgan regularly ties together related areas like Cancer in his Bone marrow studies.
His studies examine the connections between Oncology and genetics, as well as such issues in Clinical trial, with regards to Randomized controlled trial.
Between 2017 and 2021, his most popular works were:
- The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report (592 citations)
- Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. (149 citations)
- A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis (125 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary areas of investigation include Multiple myeloma, Internal medicine, Oncology, Transplantation and Cardiology.
His Multiple myeloma research incorporates elements of Survival rate, Cancer research, Maintenance therapy and Bone marrow.
His biological study spans a wide range of topics, including Cancer, Genetic heterogeneity, Gene signature and Mesenchymal stem cell.
Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology.
His study in Oncology is interdisciplinary in nature, drawing from both Risk stratification, Proportional hazards model and MEDLINE.
Gareth J. Morgan has researched Lenalidomide in several fields, including Thalidomide and Bortezomib.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
